Brief: Omega Healthcare Increases 2025 AFFO Guidance To $3.04-$3.07 Per Share

Omega Healthcare Investors,

31/07/2025 22:29

Repeats to attach to corrected alerts, no changes to text

Overview

Omega Q2 net income rises to $140 mln, up from $117 mln last year

Company completed $527 mln in new investments during Q2

Revenue missed analyst expectations, per LSEG data

Outlook

Omega raises 2025 AFFO guidance to $3.04-$3.07 per share

Company expects Genesis to pay full rent during bankruptcy

Omega sees favorable operating metrics and active investment pipeline

Company highlights strong balance sheet for future investments

Result Drivers

INVESTMENTS - Completed $527 mln in new investments, including $502 mln in real estate acquisitions

LEASE RESTRUCTURING - LaVie bankruptcy led to lease restructuring, maintaining rent income

BANKRUPTCY SUPPORT - Genesis bankruptcy supported by $8 mln DIP financing, ensuring rent payments

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
$282.50 mln
$293 mln (5 Analysts)
Q2 Net Income
$140 mln
Q2 Adjusted FFO
$232 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the specialized reits peer group is "buy"

Wall Street's median 12-month price target for Omega Healthcare Investors Inc is $40.00, about 2.9% above its July 30 closing price of $38.83

The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 23 three months ago

Press Release: ID:nBw5YqJ8ba

 (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)